Canadian Pharmacy Online Exposes Promising Lupus Treatment

Nov 28
08:08

2011

Remcel Mae P. Canete

Remcel Mae P. Canete

  • Share this article on Facebook
  • Share this article on Twitter
  • Share this article on Linkedin

Lupus is a persistent autoimmune illness that can affect about any portion of the body.

mediaimage

Lupus is a persistent autoimmune illness that can influence about any portion of the body,Canadian Pharmacy Online Exposes Promising Lupus Treatment Articles including the skin, joints, kidneys, lungs, nervous system and other organs, based on the Office on Women's Health, part of the U.S. Department of Health and Human Services.  Though several Canada drugs are available to alleviate such illness but its cure is still to be found.

"This is an incredibly exciting time in lupus research. The academic and pharmaceutical communities are involved in studies that will hopefully lead to more effective and safer treatments," said Dr. Cynthia Aranow, an investigator at the Feinstein Institute for Medical Research in Manhasset, N.Y. She was not involved in the current studies.

"It's exciting to see that they were able to reverse some of the immunologic dysfunction associated with lupus, but we need a large randomized clinical trial to confirm this," said Aranow.  Nevertheless, patients suffering from both lupus and high cholesterol need to buy Crestor to prevent complications.

"We were able to demonstrate that the IFNa signature in excess in lupus patients can be turned down by vaccinating patients against their own IFNa. The drug is called IFNa-Kinoid. It's a modified IFNa, devoid of IFNa biological activity, but modified in such a way that it becomes recognized by the immune system of the patient," explained Dr. Frederic Houssiau, head of rheumatology at the Catholic University of Louvain in Brussels.

He said "the patient's immune system then begins to make antibodies against their own INFa.

Houssiau's team, along with colleagues from the manufacturer of the vaccine, Neovacs, found the drug to be well tolerated with no significant side effects."

"This is an early, first step. It appears to be safe. And, the fact that they could show that they could inhibit or down-regulate the interferon signature is very promising," said Aranow.

"For people living with lupus," he added, "there is hope. By unraveling more and more pathways at work in lupus patients, we are now able to develop new, much more targeted drugs to tackle the disease." 

Further, it is a guarantee that these meds will soon be available on your nearest Canadian drugstore online .